| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | Ft23.64 |
| 52 Week High | Ft25.50 |
| 52 Week Low | Ft21.26 |
| Beta | 0.39 |
| 1 Month Change | 2.52% |
| 3 Month Change | -3.04% |
| 1 Year Change | 8.84% |
| 3 Year Change | -1.01% |
| 5 Year Change | 35.55% |
| Change since IPO | 264.25% |
Recent News & Updates
Recent updates
Shareholder Returns
| RIG2 | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 2.8% | 2.3% | 0.5% |
| 1Y | 8.8% | -28.6% | 1.3% |
Return vs Industry: RIG2 exceeded the German Pharmaceuticals industry which returned -28.2% over the past year.
Return vs Market: RIG2 exceeded the German Market which returned 2.3% over the past year.
Price Volatility
| RIG2 volatility | |
|---|---|
| RIG2 Average Weekly Movement | 4.9% |
| Pharmaceuticals Industry Average Movement | 6.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: RIG2 has not had significant price volatility in the past 3 months.
Volatility Over Time: RIG2's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1901 | 11,603 | Gabor Orban | www.gedeonrichter.com/hu-hu |
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. researches, develops, manufactures, markets, and sells pharmaceutical products worldwide. It operates through two segments, Pharmaceuticals, and Wholesale and Retail.
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. Fundamentals Summary
| RIG2 fundamental statistics | |
|---|---|
| Market cap | €4.22b |
| Earnings (TTM) | €404.48m |
| Revenue (TTM) | €2.05b |
10.4x
P/E Ratio2.1x
P/S RatioIs RIG2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RIG2 income statement (TTM) | |
|---|---|
| Revenue | Ft805.16b |
| Cost of Revenue | Ft283.83b |
| Gross Profit | Ft521.32b |
| Other Expenses | Ft362.47b |
| Earnings | Ft158.85b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 26, 2024
| Earnings per share (EPS) | 869.11 |
| Gross Margin | 64.75% |
| Net Profit Margin | 19.73% |
| Debt/Equity Ratio | 6.0% |
How did RIG2 perform over the long term?
See historical performance and comparison